The London Fund is an investment and advisory firm focusing on IP-rich, high-growth companies in the B2C and emerging tech sectors, particularly those leveraging transformative technologies. They partner with companies generating $1M to $100M in revenue, offering early-stage and growth capital ranging from $200K to $50M. Their typical investment rounds include Seed, Series A, and Post-IPO Equity.
The firm provides comprehensive support to entrepreneurs, including strategies for inorganic growth, mergers and acquisitions, debt and equity financing, IP strategy, and IPOs. Notable portfolio companies include Akerna, Artisse AI, Elo Health, Engin Sciences, and Price.com. The London Fund's key partners bring extensive experience from leading industry roles, enhancing their ability to drive significant value for their portfolio companies.
The London Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
